The cell biology of antigen presentation in dendritic cells

Current Opinion in Immunology

Volumn 13, Issue 1, 2001, Pages 45-51

  Thery C ^a   Amigorena, S ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN PRESENTATION; CELL MEMBRANE TRANSPORT; CELL MIGRATION; CYTOLOGY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0035140119     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00180-1     Document Type: Review

References (64)

1. Dendritic cells and the control of immunity
2. The role of aquaporins in dendritic cell macropinocytosis
3. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
4. Dendritic cells: Unique leukocyte populations which control the primary immune response
5. Fc gamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
6. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation
7. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
8. Receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
9. Cross-presentation of glycoprotein 96-associated antigens on major histocompafibility complex class I molecules requires receptor-mediated endocytosis
10. + cells
11. CD91: A receptor for heat shock protein gp98
12. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
13. The αvβ5 integrin recruits the CrkII/Dock180/Rac1 molecular complex for phagocytosis of apoptotic cells
14. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules
15. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo
16. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
17. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
18. Developmental control of endocytosis in dendritic cells by Cdc42
19. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation
20. Invariant chain structure and MHC class II function
21. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules
22. Antigen presentation mediated by recycling of surface HLA-DR molecules
23. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
24. Developmental regulation of MHC class II transport in mouse dendritic cells
25. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells
26. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading
27. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice
28. Cathepsin S required for normal MHC class II peptide loading and germinal center development
29. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells
30. Dendritic cell maturation and antigen presentation in the absence of invariant chain
31. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism
32. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein
33. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
34. Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells
35. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L
36. Transport of peptide-MHC class II complexes in developing dendritic cells
37. Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells
38. Extracellular antigen processing and presentation by immature dendritic cells
39. Abundant empty class II MHC molecules on the surface of immature dendritic cells
40. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells
41. Functional HLA-DM on the surface of B cells and immature dendritic cells
42. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
43. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
44. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation
45. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
46. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
47. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
48. Cytotoxic T-cell immunity to virus-infected non-hematopoietic cells requires presentation of exogenous antigen
49. + T cell responses to infectious agents, tumors, transplants, and vaccines
50. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
51. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells
52. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
53. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
54. Natural adjuvants: Endogenous activators of dendritic cells
55. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules
56. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
57. Immunobiology of dendritic cells
58. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
59. Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment
60. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
61. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes
62. B lymphocytes secrete antigen-presenting vesicles
63. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
64. Molecular characterization of dendritic cell-derived exosomes: Selective accumulation of the heat shock protein hsc73